Volgen
Piet B
Piet B
Radboudumc
Geen geverifieerd e-mailadres
Titel
Geciteerd door
Geciteerd door
Jaar
Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161
JM Mjösberg, S Trifari, NK Crellin, CP Peters, CM van Drunen, B Piet, ...
Nature Immunology 12 (11), 1055-1062, 2011
13062011
Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells
P Hombrink, C Helbig, RA Backer, B Piet, AE Oja, R Stark, G Brasser, ...
Nature immunology 17 (12), 1467-1478, 2016
4152016
CD8+ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung
B Piet, GJ de Bree, BS Smids-Dierdorp, CM van der Loos, ...
The Journal of clinical investigation 121 (6), 2254-2263, 2011
2012011
Trigger-happy resident memory CD4+ T cells inhabit the human lungs
AE Oja, B Piet, C Helbig, R Stark, D Van Der Zwan, H Blaauwgeers, ...
Mucosal immunology 11 (3), 654-667, 2018
1482018
Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes with a resident memory phenotype in NSCLC
AE Oja, B Piet, M Mensink, S de Kivit, MA Nolte, R Stark, P Hombrink
Frontiers in Immunology 9, 399954, 2018
1082018
Multicenter comparison of molecular tumor boards in the Netherlands: definition, composition, methods, and targeted therapy recommendations
B Koopman, HJM Groen, MJL Ligtenberg, K Grünberg, K Monkhorst, ...
The Oncologist 26 (8), e1347-e1358, 2021
392021
Programmed cell death-1/ligand-1 PET imaging: a novel tool to optimize immunotherapy?
SR Verhoeff, MM van den Heuvel, CML van Herpen, B Piet, ...
PET clinics 15 (1), 35-43, 2020
392020
Analysis of stem-cell-like properties of human CD161++ IL-18Ra+ memory CD8+ T cells
SHC Havenith, S La Yong, SM Henson, B Piet, MM Idu, SD Koch, ...
International Immunology, 2012
372012
Mechanisms of immune checkpoint inhibitor-mediated colitis
H Westdorp, MWD Sweep, MAJ Gorris, F Hoentjen, MJ Boers-Sonderen, ...
Frontiers in Immunology 12, 768957, 2021
282021
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapies
JI Scott, L Mendive-Tapia, D Gordon, ND Barth, EJ Thompson, Z Cheng, ...
Nature communications 13 (1), 2366, 2022
272022
Recent advances and future perspective of DC-based therapy in NSCLC
IAE van der Hoorn, G Flórez-Grau, MM van den Heuvel, IJM de Vries, ...
Frontiers in Immunology 12, 704776, 2021
132021
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination
LL van der Woude, MAJ Gorris, IMN Wortel, JHA Creemers, K Verrijp, ...
Journal for ImmunoTherapy of Cancer 10 (10), 2022
112022
Mechanisms, management and prevention of pemetrexed-related toxicity
N de Rouw, B Piet, HJ Derijks, MM van den Heuvel, R Ter Heine
Drug safety 44 (12), 1271-1281, 2021
112021
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer
LS Otten, B Piet, MM van den Heuvel, C Marzolini, RMJM van Geel, ...
European Respiratory Review 31 (164), 2022
72022
Erratum: Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells
P Hombrink, C Helbig, RA Backer, B Piet, AE Oja, R Stark, G Brasser, ...
Nature immunology 18 (2), 246-246, 2017
52017
SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
H Borghaei, F de Marinis, D Dumoulin, C Reynolds, W Theelen, ...
Annals of Oncology 35 (1), 66-76, 2024
42024
Imaging the rewired metabolism in lung cancer in relation to immune therapy
EAJ van Genugten, JAM Weijers, S Heskamp, M Kneilling, ...
Frontiers in Oncology 11, 786089, 2022
42022
Pharmacokinetically‐guided dosing to improve the efficacy of brigatinib in non‐small cell lung cancer patients
SE Koele, SW van Beek, AJ van der Wekken, B Piet, MM van den Heuvel, ...
British journal of clinical pharmacology 88 (4), 1930-1934, 2022
32022
Detection of dendritic cell subsets in the tumor microenvironment by multiplex immunohistochemistry
IAE van der Hoorn, E Martynova, B Subtil, J Meek, K Verrijp, J Textor, ...
European Journal of Immunology 54 (1), 2350616, 2024
22024
Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression
DAC van den Haak, LS Otten, HJPM Koenen, RL Smeets, B Piet, ...
Clinical and Translational Science 16 (6), 978-986, 2023
22023
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20